C-MEDICAL AS

0369 OSLO

Finances

Return on Equity

118,67 %

Current Ratio

0,49

Debt-to-Equity Ratio

−1,68

Key figures (NOK)	2022	2021	2020	2019
Revenue	48 766 000	37 765 000	35 495 000	31 228 000
Net Income	−25 128 000	−13 896 000	−16 923 000	−12 686 000
Total Assets	86 649 000	70 853 000	70 355 000	56 913 000
Total Equity	−21 175 000	−21 047 000	−5 453 000	−3 529 000

Income (NOK)	2022	2021	2020	2019
Revenue	48 766 000	37 765 000	35 495 000	31 228 000
Expenditure	62 884 000	51 252 000	53 551 000	45 599 000
Operating Profit	−14 118 000	−13 487 000	−18 056 000	−14 371 000
Financial Income	925 000	582 000	442 000	76 000
Financial Costs	15 916 000	4 227 000	3 972 000	1 964 000
Financial Balance	−14 991 000	−3 645 000	−3 530 000	−1 888 000
Earnings Before Tax	−29 110 000	−17 133 000	−21 586 000	−16 258 000
Tax	−3 982 000	−3 237 000	−4 663 000	−3 571 000
Net Income	−25 128 000	−13 896 000	−16 923 000	−12 686 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	51 328 000	50 610 000	55 691 000	49 159 000
Total Current Assets	35 321 000	20 243 000	14 664 000	7 754 000
Total Assets	86 649 000	70 853 000	70 355 000	56 913 000
Total Retained Equity	−89 076 000	−63 948 000	−48 354 000	−31 431 000
Total Equity	−21 175 000	−21 047 000	−5 453 000	−3 529 000
Total Long-Term Debt	35 601 000	60 985 000	57 149 000	46 678 000
Total Current Debt	72 223 000	30 915 000	18 659 000	13 764 000
Total Equity and Debt	86 649 000	70 853 000	70 355 000	56 913 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	48 766 000	37 765 000	35 484 000	31 228 000
Other Income	0	0	11 000	0
Revenue	48 766 000	37 765 000	35 495 000	31 228 000
Cost of Goods Sold	30 972 000	20 523 000	17 466 000	15 429 000
Salary Costs	11 550 000	7 660 000	11 585 000	9 294 000
Depreciation	7 666 000	8 613 000	9 212 000	7 457 000
Impairment	0	0	0	0
Expenditure	62 884 000	51 252 000	53 551 000	45 599 000
Operating Profit	−14 118 000	−13 487 000	−18 056 000	−14 371 000
Financial Income	925 000	582 000	442 000	76 000
Financial Costs	15 916 000	4 227 000	3 972 000	1 964 000
Financial Balance	−14 991 000	−3 645 000	−3 530 000	−1 888 000
Dividends	0	0	0	0
Net Income	−25 128 000	−13 896 000	−16 923 000	−12 686 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	4 776 000	5 612 000	8 140 000	8 969 000
Total Intangible Assets	25 454 000	22 309 000	21 600 000	17 767 000
Real Eastate	1 322 000	795 000	839 000	0
Machinery and Plant Facilities	5 290 000	12 222 000	17 577 000	24 345 000
Fixtures	7 702 000	1 404 000	2 119 000	1 998 000
Total Tangible Assets	14 315 000	14 420 000	20 535 000	26 343 000
Total Fiancial Fixed Assets	11 560 000	13 880 000	13 556 000	5 049 000
Total Fixed Assets	51 328 000	50 610 000	55 691 000	49 159 000
Stock	205 000	1 165 000	1 360 000	1 534 000
Total Investments	0	0	0	0
Cash, Bank	540 000	1 915 000	2 095 000	936 000
Total Current Assets	35 321 000	20 243 000	14 664 000	7 754 000
Total Assets	86 649 000	70 853 000	70 355 000	56 913 000
Total Equity	−21 175 000	−21 047 000	−5 453 000	−3 529 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	35 601 000	60 985 000	57 149 000	46 678 000
Creditors	9 251 000	2 558 000	3 612 000	1 861 000
Unpaid Taxes	873 000	413 000	723 000	753 000
Dividends	0	0	0	0
Other Current Debt	62 099 000	27 945 000	14 324 000	11 150 000
Total Current Debt	72 223 000	30 915 000	18 659 000	13 764 000
Total Equity and Debt	86 649 000	70 853 000	70 355 000	56 913 000

Financial indicators	2022	2021	2020	2019
Return on Equity	118,67 %	66,02 %	310,34 %	359,48 %
Debt-to-Equity Ratio	−1,68	−2,9	−10,48	−13,23
Operating Profit Margin	−28,95 %	−35,71 %	−50,87 %	−46,02 %
Current Ratio	0,49	0,65	0,79	0,56
Quick Ratio	0,49	0,68	0,85	0,63
Equity Ratio	−0,24	−0,3	−0,08	−0,06
Gross Profit Margin	36,49 %	45,66 %	50,79 %	50,59 %